News and price dashboard

Iovance collapses on lung cancer data

IOVA is the big one today, down 35.4% after the Phase 2 lung cancer webcast. The actual numbers: IOV-LUN-202 showed a 24.6% objective response rate in 69 previously treated non-squamous metastatic NSCLC patients, 17 responses in total (15 confirmed, two unconfirmed partials), data as of October 14. A retrospective subgroup of KRAS wild-type, HER2 wild-type patients with current or former smoking history, 22 of the 69, hit a 59.1% response rate and accounted for 13 of the 17 responses. KRAS wild-type overall responded at 43.3% versus 11.4% for KRAS-mutant, and both complete responses were in KRAS wild-type tumors. Iovance plans to start enrolling POSITILITY, a biomarker-enriched registrational-intent cohort, in November 2026, with a supplemental BLA targeted for 2027 and a frontline trial, OPTILISM, also in 2027. Investor's Business Daily pinned the selloff on durability: the company did not say how long patients responded, nor did it give specific safety and tolerability results, and the stock undercut its 50-day line. Investing.com frames it as buy-the-rumor-sell-the-news, noting the stock had risen about 12% after hours on October 28 on a release that carried no efficacy figures at all, then fell 8.9% pre-open; it adds that at roughly $7 billion the company trades near 17 times the midpoint of 2026 revenue guidance, and that the hold-and-hawkish Fed plus a weak Nasdaq hurt long-duration biotech. Q3 earnings are November 5.

Aurora cuts revenue guidance, three targets come down

AUR fell 13.5%. Q3 2026 revenue came in at $3 million, in line with expectations, EPS a loss of $0.12 as estimated, but the operating loss was $257 million and the production schedule is running six weeks late. Full-year 2026 revenue guidance was cut to roughly $9 million from a prior $14 to $16 million, and the target of more than 200 driverless Generation 2 trucks slipped from year-end to end of February. Cash burn is set to rise. Against that, Aurora reaffirmed over 1,000 autonomous trucks by end-2027 at roughly $200 million revenue, more than 7,500 in 2028, and more than 30,000 by 2030 at over $5 billion revenue and a targeted gross margin above 60%; it has more than 20 trucks built and wants 20 a week by early December, with about 500,000 fully driverless miles logged since commercialization began in late April 2025. Three cuts landed on the same day: Cantor Fitzgerald to $11 from $12 (Overweight kept), Needham to $10 from $13 (Buy kept, citing a lower multiple on longer-dated growth given rates), and Goldman Sachs to $6 per a headline-only item.

Stagwell at a 52-week high on record margins

STGW rose 12.7% and touched a 52-week high of $9.64, market cap about $2.16 billion, with a one-year total return of 85.9% and 80.6% year to date. Q3 net revenue was $664 million, up 7% organically, the best in seven quarters; adjusted EBITDA $145 million, up 25%, with margin up 290 basis points to 21.8%; adjusted EPS $0.34 against a $0.31 consensus, up 42%. Total revenue of $816 million missed the $838.44 million expected. The mix shift is the story: Digital Transformation grew 23% organically and The Marketing Cloud 108%, together now 26% of net revenue, while traditional Marketing Services fell 7.5% and Media & Commerce 2.1%; Communications grew 20% on US midterm activity. Enterprise technology has $59 million committed year to date against an initial $25 million target, and the 2027 bookings goal was raised to $150 million from $75 million, tied to work with ServiceNow, Adobe and Palantir. Net new business was $168 million in the quarter and $586 million over twelve months, up 24%, including the largest-ever multi-agency engagement (ServiceNow) and a first major federal contract with US Central Command. Net leverage 2.7x, liquidity $542 million, $326 million left on the buyback, share count down 10 million year over year. Guidance was raised. Mark Penn's line was that Stagwell is becoming "the #1 Marketing Transformation company in the world."

AI infrastructure names caught in the Microsoft read-across

NBIS fell 5.7%, with two headlines tying it and CoreWeave to Microsoft's earnings, one of them referring to a "Microsoft surprise." That's all the headlines state. A separate headline notes director Arne Grimme bought 353 shares. SNDK was down 5.3% despite headlines saying it cleared fiscal Q1 targets, guided higher and announced an 8-for-1 stock split; transcript quotes have the CFO putting data center revenue at $4.8 billion, up 61% sequentially with three US hyperscalers behind it, and the CEO describing a structural increase in NAND demand extending beyond fiscal 2030. One headline flags the stock down about 2% after hours, another has Micron and SanDisk falling as a Samsung selloff hit memory names. WULF was down 5.0% and DDOG 4.5%, both with headline-only items that don't explain the moves.

Oracle slips after its analyst day rally

ORCL fell 3.4% today, which sits awkwardly against a thick cluster of headlines describing a 10-11% surge after its analyst day on an accelerated free cash flow timeline, AI chip strategy and AI partnerships that eased financing worries. Today's headlines point the other way: a decline tied to a $20 billion financing ceiling, and a Scotiabank price target trim. Targets elsewhere were held, not cut: TD Cowen at $240, Oppenheimer at $275, Piper Sandler at $225, with Melius reiterating Buy on the AI infrastructure path. Worth a look if you hold it, since the analyst-day enthusiasm and today's move are pulling in opposite directions.

Earnings and analyst notes across the rest

BFLY was down 3.8% on Q3 revenue of $32.6 million, with one headline calling it an earnings beat with strong revenue growth. MOD fell 3.3% as B. Riley kept a Buy but lowered its target to $285. XENE rose 3.3%, with a headline saying it is advancing pain drugs into Phase 2. Elsewhere the analyst flow leaned positive: Amphenol (+1.4%) had target raises from BNP Paribas to $115, UBS to $111 and Truist to $112 after record Q3 results, though one headline says it lowered Q4 adjusted EPS guidance; Vertiv (+1.2%) had TD Cowen to $357 and Wells Fargo to $345, with Q3 sales up 61%; Generac (+1.0%) drew four raises, Barclays $281, Stifel $325, Needham $288 on data center growth, and Jefferies reiterating Buy at $279. Going the other way, PayPal (+0.7%) was downgraded by Barclays with the target cut to $53 on slowing checkout growth, and UBS trimmed to $60. Jefferies downgraded KOS (-2.9%) while raising its target to $2.90, and Maxim Group cut DVLT (-8.9%) to Hold. Marathon Petroleum (-1.9%) raised its quarterly dividend 10% to $1.10.

Quiet names and unexplained movers

CELU was down 9.7% with only an 8-K covering Item 8.01 Other Events to go on, so there's no stated reason in the material. Avery Dennison (+0.8%) beat on earnings and revenue with Q3 net sales of $2.3 billion, Pagaya (+1.7%) beat with revenue of $390 million versus $382.72 million expected and raised full-year net income guidance, Exelixis (-0.1%) beat by $0.07 on a revenue topper, and Incyte (-0.1%) reported revenue of $1.56 billion ahead of estimates while missing EPS by $0.07, with core business up 37%. Apple rose 1.5% amid a large volume of ETF-flow and chart items with no real news behind them. The remainder of the list is routine filings, index-fund rebalancing notes and commentary that doesn't need your time.

Iovance drops 28% on lung cancer data

IOVA is down 28.2%, and the full data release explains it. Iovance reported a 24.6% objective response rate for lifileucel in 69 previously treated non-squamous metastatic NSCLC patients from the Phase 2 IOV-LUN-202 trial, data as of October 14: 17 responses, 15 confirmed and two unconfirmed partial. The standout was a retrospective subgroup of KRAS wild-type, HER2 wild-type patients with current or former smoking history, 22 of the 69, which showed a 59.1% response rate and accounted for 13 of the 17 responses. KRAS wild-type patients overall responded at 43.3% versus 11.4% for KRAS-mutant, and both complete responses were in KRAS wild-type tumors. The company will start enrolling POSITILITY, a biomarker-enriched registrational-intent cohort, in November 2026, plans a supplemental BLA in 2027, and intends to start a frontline trial, OPTILISM, in 2027. Investing.com's separate piece frames the move as buy-the-rumour, sell-the-news: the stock had risen about 12% after hours on October 28 on the headline announcement, which carried no efficacy figures, then reversed into the webcast. That article also notes a roughly $7 billion market value, near 17 times the midpoint of 2026 revenue guidance for a company not yet profitable, cites the Fed's October 28 hold at 3.75–4% with two dissents wanting a hike, higher long-end yields, and a weak Nasdaq as added pressure on long-duration biotech. Q3 earnings are November 5.

Vertiv up 16.5% on Q3 beat and raise

VRT is up 16.5% after Q3 2026 adjusted EPS of $2.21 against a $1.82 estimate on revenue of $4.31 billion versus $3.75 billion expected, sales up 61% year on year, with adjusted operating margin of 25.2%, up 290 basis points. Organic orders grew more than 100%, and CEO Gio Albertazzi said "we are not talking about catch-up here," with the Americas pipeline growing at its fastest sequential pace this year and EMEA roughly doubling. Full-year guidance went up: net sales to $14.65 billion (+$650 million), adjusted EPS to $7.15 (+$0.45), operating profit above $3.5 billion, margin to 24%. Q4 is guided to about $4.4 billion revenue and $2.25 EPS at the midpoint, modestly above the $2.21/$4.31 billion consensus. Open questions flagged in the analysis: uneven execution (Q2 revenue missed, Q4 FY2025 EPS missed by 12.3%), capacity expansion risk in Slovakia, Ireland and the Americas, and no 2027 guidance yet. Wells Fargo lifted its target to $345 from $340 with an Overweight, saying Q3 unwound the execution worries that built up after Q2, that it found no evidence of product ramp issues, and that the Q4 margin target of 26% is already close to the 27% 2030 goal. The GuruFocus headlines on the surge, the raised guidance and the order growth all point at the same release.

Oracle up 10.7% after Investor Day

ORCL is up 10.7% on the back of its Investor Day. The company set a fiscal 2030 revenue target above $225 billion, implying over 35% annualised growth, with free cash flow turning positive in the second half of fiscal 2028 and exceeding $30 billion by 2029 as capex starts declining. Crucially for the debt worry, Oracle said it will cap additional financing through fiscal 2030 at $20 billion, split evenly between debt and equity. Melius reiterated Buy with a $170 target, noting the free cash flow turn comes about a year earlier than it had assumed, that FY2027 and FY2028 are peak capex years, and that management expects to add roughly 7 gigawatts of capacity to reach about 10 gigawatts by end of FY2028, with OCI benefiting from more OpenAI business and from offering Google's TPU, Cerebras and Nvidia's Vera Rubin. The $170 target is 10 times Melius's FY2029 EPS estimate of $16.76. Headline-only items add that Piper Sandler kept its $225 target, that FY2027 revenue of $90 billion was reaffirmed, and separate pieces on Google opening its AI chips to Oracle and Nvidia Vera CPUs landing on Oracle Cloud. The TradingView piece ties Oracle's cash flow promise to Microsoft actually delivering, with Azure revenue up 48% and free cash flow of $18.6 billion.

Smaller movers with earnings behind them

Butterfly Network is down 8.8% despite headlines saying Q3 beat, with revenue of $32.6 million. Nebius is up 7.0%, though the only item is a headline asking why CoreWeave and Nebius are sinking after Microsoft earnings, so the headline and the quote point opposite ways. TeraWulf up 6.0% and Micron up 5.9% have only commentary and valuation-screen headlines attached, nothing substantive. Incyte is down 4.8% after Q3 revenue of $1.56 billion that topped estimates while EPS missed by $0.07. Aurora Innovation is down 4.7% after reporting Q3 revenue of $3 million and an operating loss of $257 million, with headlines citing driverless fleet expansion alongside production delays. Stagwell is down 4.2% on record Q3 revenue of $816 million but EPS of $0.07 against a $0.26 estimate.

Analyst notes and quiet names

PayPal, up 0.8%, drew a cluster of notes: Barclays cut its rating on slowing checkout growth, UBS lowered its target to $60 and Citigroup to $58, while BMO raised to $59 and TD Cowen to $60. Generac is flat but had Needham raise to $288 on data centre growth, Jefferies reiterate Buy at $279, and a record Q3 with a $2.4 billion Amazon supply deal. Marathon Petroleum, up 1.3%, raised its quarterly dividend 10% to $1.10. Apple is up 1.1% with product news, the new M6 MacBook Pro and iMac including a touchscreen notebook, Macs set for November 6, plus a Bernstein SocGen Outperform reiteration on share gains. Avery Dennison, down 0.6%, beat on earnings and revenue. SpaceX is down 1.8%, with headlines on a lawsuit over the tax deal behind its $100 billion Louisiana project and Alphabet's CFO attributing a negative $8.2 billion in other income largely to an unrealised loss on its SpaceX stake. The rest of the list, including the long run of Planet MicroCap Showcase items tagged to PL, is ETF flow noise, routine 8-Ks and earnings calendar entries with no real movement behind them.

Vertiv blows out Q3 and raises guidance

Vertiv is up 16.5%, and it's the one name here with real substance behind the move. Q3 adjusted EPS was $2.21 against a $1.82 consensus, a 21.4% beat, on revenue of $4.31 billion versus $3.75 billion expected, up 61% year over year. Adjusted operating margin came in at 25.2%, up 290 basis points, and operating profit of $1.087 billion beat the guidance midpoint by $169 million. Adjusted free cash flow was $652 million, up 50%, and net leverage was negative 0.2x. Regionally the Americas did $2.99 billion, up 75%, APAC $779 million up 50%, and EMEA $545 million up 23%, with EMEA margin jumping from 18.8% to 28.0%. The headline number for the demand debate was organic orders up more than 100% year over year. Management raised full-year 2026 guidance across the board: sales to $14.65 billion (+$650 million), adjusted EPS to $7.15 (+$0.45), operating profit to roughly $3.515 billion (+$190 million), margin to 24%, and free cash flow to $2.7 billion. Q4 is guided to $2.25 EPS on about $4.4 billion with a 25.8% margin, modestly above the $2.21 consensus. No 2027 guidance yet, only language about continued above-market organic growth.

What the Vertiv call actually addressed

The call was framed around answering the bear case that built up after the stock fell 15.6% on Q2 in July. Executive Chairman Dave Cote opened with "the rumors of our demise have been greatly exaggerated." CEO Gio Albertazzi said the order growth is not catch-up demand, pointing to the Americas pipeline growing at its fastest sequential pace this year and the EMEA pipeline roughly doubling. An Evercore analyst argued orders running well above AI capacity additions imply share gains, which cuts against the earlier product-quality and share-loss worries. Management did confirm that $100 to $150 million of revenue delayed from Q2 by supply chain problems landed in Q3. The caveats management itself flagged: inventory up more than 100% year over year, growth that Albertazzi called "not always orderly," capacity expansion in Slovakia, Ireland and the Americas carrying execution risk, and pacing factors in power availability, permitting and skilled site labor. Backlog counts only signed purchase orders, not capacity agreements, with lead times still 12 to 18 months. Two acquisitions closed in the quarter: UtilityInnovation Group on Oct 26 for microgrid and power controls, and King Environmental Services on Oct 23 for fluid management and load testing in Europe. The 800-volt DC roadmap is on track with revenue expected to start in 2027. Schaeffer's notes the stock is up 48% year to date after sitting at eight-month lows on Friday, pacing for its best session since a 24.5% pop on Feb 11, and that the 50-day put/call ratio of 1.23 sits in the 100th percentile, so positioning going in was unusually bearish. Investing.com's own note points out consensus of $6.72 FY26 and $9.19 FY27 hadn't been revised yet at the time of writing.

Oracle investor day targets

Oracle is up 10.7% on its 2026 investor day, all headline-only here, but the figures are stated across several of them consistently: at least $225 billion in revenue by fiscal 2030, implying over 35% annualized growth, with 40% operating margins, $21 EPS and $30 billion of free cash flow by fiscal 2029, and the FY2027 revenue target of $90 billion confirmed. One headline says Oracle expects to turn cash flow positive in the second half of fiscal 2028. Separately, headlines report Nvidia's Vera CPUs becoming available on Oracle Cloud and Google opening its AI chips to Oracle. The 8-K filed today is a Regulation FD disclosure, consistent with the investor day materials.

BEAM ticker ambiguity

The BEAM line is up 15.6%, but the two items under it don't match each other. The full-text piece is a TradingView technical note on the BEAM crypto token on Bybit, not the equity, discussing a resistance zone at $0.00350–$0.00356 and citing a Q3 ecosystem treasury of about $160.04 million. The only equity item is a headline saying Wedbush maintained its rating and lowered its target to $28.00. Nothing in the material explains a 15.6% move in the stock, so this one is worth checking directly.

Memory, AI infrastructure and the rest of the complex

SanDisk is up 7.7% with an Investing.com piece asking why it's rallying and a GuruFocus headline noting Wall Street sees 63% upside into earnings, plus unusual option activity. Micron is up 5.9%, with headlines tying it to SK hynix's record Q3 profit and AI-driven memory shortages. Nebius is up 7.0% on what GuruFocus calls a broad rebound in neocloud stocks, alongside two technical notes on reclaiming the 200 SMA. TeraWulf is up 6.0% with only a technical chart item behind it. Amphenol is up 3.5% after a Q3 beat on AI demand, with EPS of $0.79 reported and the headline saying it beat by $0.08; separately, Industrial Growth Partners is selling AdvancedPCB to Amphenol. Generac is up 3.9% on record Q3 sales, a $2.4 billion Amazon supply deal, a data center backlog reported at $4.5 billion, and an EPS beat with a revenue miss. Broadcom is up 2.8% on headlines linking the Anthropic financing to both sales and asset risk. The common thread across Vertiv, Amphenol, Generac, Micron, SanDisk and Nebius today is AI data center buildout, and the day's reports mostly came in strong.

Quieter names and the PayPal note cluster

PayPal is barely moved at +0.8% but drew seven analyst notes today after earnings, with targets moving in both directions: Citi lowered to $58, BMO raised to $59, TD Cowen raised to $60, Evercore ISI raised to $45, Morgan Stanley raised to $46, and Canaccord held at $55, while one piece flags a warning signal from its largest business. Apple is down 0.9% having launched a touchscreen OLED MacBook Pro, with M6 Macs headlined for November 6 and Monness raising its target to $355 from $335 ahead of November 2 earnings. SpaceX is down 2.3%, with headlines on a tax-deal lawsuit against its $100 billion Louisiana project and Putin calling Musk "a true genius" at the Russia-Africa Summit. BigBear.ai reported Q3 revenue of $43.6 million and raised FY2026 guidance, up 4.7%, though Cantor Fitzgerald cut its target to $3.00. Netflix hit a 52-week low at $61.65. The rest is routine: price target tweaks on Datadog, Mercury Systems, NuScale and Ur-Energy, DCF notes on Comcast, Aflac and Wheaton, earnings previews for Pagaya, Incyte and Aurora, and Exelixis at an all-time high of $65.62.

Planet Labs tag artifact

The long run of Planet MicroCap Showcase Toronto 2026 items tagged PL, down 1.1%, are company presentations from unrelated microcaps picked up by ticker matching. There's nothing about Planet Labs itself in any of them.

Vertiv blows past Q3 estimates

Vertiv is the day's big move, up 15.3% on a Q3 that beat on every line. Adjusted EPS came in at $2.21 against $1.82 consensus, revenue at $4.31 billion versus $3.75 billion expected, up 61% year over year, with organic orders more than doubling. Full-year 2026 guidance went up to $7.15 EPS and $14.65 billion revenue, against prior consensus of $6.73 and $13.99 billion; Q4 guidance of $2.25 EPS and $4.41 billion also sits above the Street. Alongside the print, Vertiv confirmed it closed the $1.45 billion acquisition of UtilityInnovation Group, which adds power generation and grid-connection capability for high-density AI data centres, and which management had said would be accretive to adjusted EPS within the first year. Investing.com makes the point that the triple-digit order growth directly answers the concern that had been weighing on the stock, that delayed AI infrastructure shipments were suppressing revenue conversion. Context on the starting point: shares closed at $208.56 the prior session, down nearly 14% over three months and roughly 45% below the $379.94 52-week high. Bank of America's Andrew Obin had reiterated Buy with a $375 target ahead of the print expecting a beat-and-raise. The broad market was mixed that morning, so the move was company-specific. There's also an 8-K on file covering results, Reg FD and exhibits, plus a TradingView chart post framing it as a gap-up out of a six-month base, and several GuruFocus headline pieces restating the same numbers.

Modine severance overhaul

Modine is up 5.9%, and the only substance behind it in this list is an 8-K on executive compensation, not operating news. The board approved a new Executive Severance Plan on October 21 and 22, replacing the prior Supplemental Severance Plan. CFO Michael Lucareli gets 1.5 times salary plus target bonus on a qualifying termination, 2.5 times within 24 months of a change in control; General Counsel Erin Roth is at 1.0 and 2.0. CEO Neil Brinker, outside both plans, was amended to two times salary and target bonus, three times on a change-in-control termination. Lucareli's prior change-in-control agreement was terminated. Performance stock and RSU agreements were also amended to change how performance is calculated in a change of control and to widen "good reason" to include a material change in title. The article notes shares were at $136.51, down 42% over six months, and flags recent items in the background: a planned rebrand to Modexus Solutions after the Gentherm merger and Performance Technologies spin-off pending shareholder approval, D.A. Davidson reiterating Buy at $330, and KeyBanc at Overweight with a $280 target. The filing itself gives no reason for today's move.

Amphenol beat and raise

Amphenol is also up 5.9% after Q3 EPS of $0.80 versus $0.72 expected and revenue of $10.2 billion against $9.44 billion consensus. Q4 guidance is $0.81 to $0.83 on EPS versus $0.76 consensus, and full-year 2026 is $2.82 to $2.84 against $2.69. Shares closed at $78.21 beforehand, down 2.7% over three months. Worth noting it had 13 positive EPS revisions and zero negative in the prior 90 days, so the direction was already being telegraphed. The report came before the open on a heavy earnings day that also includes Alphabet and Microsoft after the close.

The AI infrastructure cluster

Vertiv, Amphenol, Modine, SanDisk and Micron are all green today and they're the same trade from different angles, power and cooling, connectors, memory. Micron is up 3.6%, with headline coverage tying it to SK Hynix's Q3 profit beat and broader semiconductor optimism. SanDisk is up 4.4%; the Investing.com piece asking why is headline-only, so I can't tell you the reason behind it. Broadcom is up 1.9% on a busy but headline-only docket: Fitch affirmed the A- rating with a positive outlook despite AI backstop risks, an 8-K discloses a direct financial obligation, and a separate headline cites a $43 billion residual value backstop tied to custom AI rack leases. Rosenblatt kept its $600 target. Arista is up 2.0% and Nebius up 1.4%, both on headline-only notes.

BigBear.ai down on a mixed print

BigBear.ai is down 2.0% despite reporting Q3 revenue of $43.6 million, up 31%, and raising full-year guidance. Headlines indicate revenue beat but EPS missed. Cantor Fitzgerald maintained its rating and cut the target to $3.00. All headline-only here, so I can't give you the detail from the call.

PayPal analyst crossfire

PayPal is down 1.3% with a cluster of conflicting notes, all headline-only: Morgan Stanley raised to $46, BofA raised to $54 on a model update while keeping an Underperform rating, UBS cut its target citing a balanced growth strategy, and Needham reiterated Hold. One headline says PayPal lifted its 2026 EPS outlook to $5.60.

Oracle's news flow without the move

Oracle has by far the heaviest item count in the list and the smallest move, up 0.4%. The headlines cover a Google TPU partnership, an expanded OpenAI tie-up integrating ChatGPT and Codex, Snowflake AI Data Cloud on OCI, a new Media Fabric product, FedRAMP Class D certification plans, an expanded Nvidia chip deal with Google and Cerebras options, Form 4s from Catz, Henley, Smith and Levey, and Evercore raising the question of AI funding needs. Nothing here was read in full, and none of it is moving the stock today.

Quiet across the rest

The rest of the list is noise relative to position sizing. Apple is flat at -0.1% under a wall of ETF flow items and a Monness Crespi target raise to $355 ahead of November 2 earnings. Netflix is off 0.6% with a headline noting it's entering oversold territory and a director sale. Generac reported Q3 net sales of $1.29 billion with EPS beating by $0.11 but revenue short, and the stock is unchanged. Wheaton Precious Metals is up 2.9%, Lufax down 1.4% after a wider Q3 loss on rising credit costs, Bradesco downgraded to Neutral by Citigroup, Kosmos downgraded to Hold by Jefferies on valuation. SpaceX is down 0.8%, with BofA adding it to its US 1 list on one headline and Musk voicing concerns on neoclouds on another. Nothing in that group needs a closer look today.

Datavault AI down by half with no news behind it

DVLT is down 49.5%, the biggest move on the list, and nothing in the material explains it. The two items carrying the ticker are both the same TradingView chart post from the same user, claiming a double bottom completed at $0.0625 with targets of $4.00 and $8.00. That's a retail chart opinion, not company news, and it predates nothing that would account for the drop. If you want a reason for today's move, it isn't here.

Neocloud rebound led by Nebius

Nebius is up 11.2%, and this one is well documented. A French media report said the company raised roughly €250 million (about $279 million) for its planned data center near Lille, part of a wider €8 billion plan to turn a former Bridgestone site into a 240 megawatt AI compute facility. The timing matters: days earlier CEO Arkady Volozh had said asset-backed financing and parts of the debt market had tightened, and Elon Musk had posted that over 200 neocloud providers faced failures and consolidation. The raise cut against the idea that Nebius was shut out of funding. A company director also bought about $122,700 of stock. Bank of America's Tal Liani kept a Buy, citing the $3.5 billion Citi credit facility and more than $40 billion in long-term customer commitments. Adding to it, Anthropic filed for an IPO at a targeted $1.5 to $2 trillion valuation with large disclosed compute commitments, and the Fed held rates steady at the October 27-28 meeting. The stock had fallen roughly 35% from its October highs before this. The move was sector-wide, not just Nebius: a Walter Bloomberg post on X had Nebius up 11.1%, CoreWeave up 6.7% and IREN up 7.7%. Nasdaq 100 movers and a GuruFocus piece on the AI cloud financing debate cover the same day from headline angle only.

Smaller gainers with company news

NB is up 17.6%, flagged only in a Nasdaq headline on Tuesday sector leaders in metals, mining, rubber and plastics, so there's no company-specific detail. BigBear.ai is up 10.8% on an 8-K filing under Item 2.02, results of operations, which is a headline-only item and gives no figures here. Vuzix is up 9.3% after signing a distribution agreement with Commercial Electronics Systems, a Denver-based security and fire protection distributor, along with an initial six-figure order for LX1 smart glasses that has already begun shipping. CES is folding Vuzix into a new Automation and Intelligent Infrastructure division and serves Colorado, Texas and Wyoming. The release also noted CES customer Merge Solutions using M400 glasses in surgical procedures, including live X-ray streaming.

Xometry ahead of Nov 3 earnings

Xometry is up 7.9%. Cantor Fitzgerald reiterated Overweight with a $110 target on Monday, with the stock around $90.05 and up 79% over the past year. Cantor expects a beat on November 3, based on demand signals from a third-quarter service bureau survey. Management guided revenue growth of 33% to 34% with 37% marketplace growth and adjusted EBITDA of $60 to $62 million; Cantor models 33.5% and thinks guidance may prove conservative, pointing to reshoring, tariffs and growing production exposure. Context from the piece: Q2 came in at $0.16 adjusted EPS on $229.3 million revenue, up 41%, against expectations of $0.15 and $213.4 million. Rosenblatt is at $120 Buy, Citizens at $120 Market Outperform, JPMorgan initiated Overweight at $120.

Refiners sold off, Russia gas headline

MPC is down 7.4%. The two items filed under it are GuruFocus ETF-flow headlines about XOP adding APA and Murphy Oil and XLE buying more Exxon, neither of which explains the refiner selloff. Worth noting the Investing.com market tables in today's articles show the same group down together, with VLO down 9.24% and PSX down 7.03%. Separately, an item tagged CAN (+7.5%) is actually a Walter Bloomberg post quoting Novak saying Russia can reroute and sell all its gas if Europe rejects it, which looks like a ticker mismatch rather than news on that name.

Joby, Coherent, Arista

Joby is up 6.8% on a set of GuruFocus headlines about Cathie Wood rotating out of AMD and TSMC and buying roughly $2 billion of the flying taxi stock; headline-only, so no detail on timing or price. Coherent is up 6.5% with Needham maintaining its rating and cutting its target to $380. Arista is up 5.5% ahead of November 3 earnings, and the options market implies a 7.7% move on the print per Bloomberg data. The stock has exceeded that implied move in six of the last eight reports, including a 15.5% move against 9.6% implied in August and a 14.7% decline against 8.4% implied in May.

Broadcom and the Anthropic financing

Broadcom is up 4.0% on the heaviest headline cluster in the list, all pointing the same way: Broadcom helped line up $63 billion in financing for Anthropic's chips, with the deal reportedly clearing a hurdle after the CEO stepped in on a snag. D.A. Davidson upgraded with a target raised to $400; StoneX kept $545; KeyBanc reiterated Overweight on AI chip wins; Rosenblatt reiterated on the financing deal. Fitch affirmed the A- rating with a positive outlook while flagging AI backstop risks, and an 8-K was filed under Item 2.03 covering a new direct financial obligation. GuruFocus also noted residual-value exposure tied to the $63 billion financing. All headline-only, so the mechanics of the backstop aren't spelled out here.

Vertiv closes $1.45bn deal into Q3 print

Vertiv is up 4.4%, having completed its $1.45 billion acquisition of UtilityInnovation Group, confirmed by an 8-K and multiple outlets, with one GuruFocus headline flagging earnout exposure in the structure. Q3 earnings land October 28.

Oracle's AI announcement blitz

Oracle is up 3.5% on roughly thirty headlines, nearly all product and partnership announcements landing together: expanded Nvidia chip supply, Google TPUs on OCI in 2027, Cerebras inference on Oracle cloud in 2027, an Intel multiyear cloud collaboration, Snowflake as a native service, an OpenAI partnership putting ChatGPT into business applications, an AI security mesh on OpenAI models, a new AI data platform with ontology, Media Fabric, Fusion Data Intelligence agents, added AI networking features and a planned FedRAMP Class D certification. Against that, Evercore says Oracle still has to answer the question of how it funds the AI buildout. Headline-only throughout.

PayPal's mixed quarter

PayPal is up 2.0% after Q3. The headlines say EPS beat while revenue of $8.6 billion and merchant volume missed, GAAP EPS was $1.25, and full-year non-GAAP guidance for transaction margin dollars and EPS was raised, with 2026 EPS outlook cited at $5.60. The CEO's quoted line was about momentum across the business. Needham stayed Hold, BTIG stayed Neutral. One GuruFocus headline says the stock fell despite the beat and raise, which sits against the quoted intraday gain, so the timing differs.

Quieter names

Everything else is minor. Accenture is down 4.9% with only a GuruFocus DCF headline ($236 intrinsic vs $247 price) attached, so no stated cause. Adobe is down 4.0% on valuation and chart headlines, again no news. VNET is down 4.1% after repurchasing 30% of its 2027 convertible notes, about $75.3 million. Modine and Kodiak Gas carry routine target maintenance notes. Apple is up 0.9% on a wide but low-impact set: M6 MacBook Pro at $1,999, a new 24-inch iMac from $1,499, updated creator apps, Evercore reiterating on the Mac launch, and separately acknowledged early iPhone Duo screen failures alongside strong preorders, with earnings Monday after the bell. SPCX is up 1.1% on Starlink mobile buildout coverage, a BofA US 1 List addition, and TD Cowen cutting Verizon's target to $55 citing SPCX competition. Datadog is flat at +0.2% despite a $320 target headline. Incyte up 2.9% has four separate reiterations (Stifel, BMO, Oppenheimer, H.C. Wainwright at $152) on cancer drug and solid tumor data, all headline-only.

Datavault AI restates, stock halved

The single biggest move on the list is DVLT, down 43%. Datavault AI announced non-reliance on previously issued financial statements and said it expects reductions of up to $92.2 million in total assets, with a matching 8-K filed under Item 4.02. Both of those are headline-only here, so the figure above and the fact of the restatement are all I can confirm. This is the one name on the page that looks worth opening properly today.

Nebius up on balance-sheet comparison and insider buy

NBIS is up 5.6%, and there are three full pieces behind it. The context is Musk's Oct 25 comment that debt markets have "almost entirely shut off access to money" for companies without substantial revenue outside AI data centres, plus his prediction of consolidation and failures among "200+ neoclouds" and his statement that SpaceX won't buy one. The selloff that followed was sector-wide: CoreWeave and Nebius had each lost more than 30% this month before rebounding on Oct 26 after Anthropic's IPO filing. Investing.com then ran the four neoclouds against each other on balance-sheet data and put Nebius first: debt/capital 19.0%, current ratio 4.0x, Altman Z of 5.9 and a +35.4% one-year return, against CoreWeave at 63.3%, 0.5x, 0.1 and -59.1%, IREN at 43.3%/3.6x/5.6/-60.4%, and Applied Digital at 45.7%/2.6x/0.6/-45.4%. Nebius carries $10.2B of debt against a $43.5B market cap; CoreWeave carries $51.6B against $29.9B. Revenue went from $91.5M in FY2024 to $529.8M in FY2025. The same piece is blunt about the other side: levered free cash flow of -$5.88B, the CEO acknowledging some funding channels had become temporarily unavailable, and the 2034 bonds at record lows. Separately, on Oct 22 Nebius took a $3.5B senior secured facility from Citi for data centres, GPU purchases and general corporate use, maturing in 364 days at Term SOFR plus 2.75 points rising to as much as 3.50, with management pointing to more than $40B in long-term contracts with investment-grade customers as a base for possible asset-backed financing. The refinancing clock on a 364-day facility funding multi-year infrastructure is the stated pressure point. On the insider side, director Arne Grimme bought 770 shares on Oct 26, taking him to 7,398; he's bought 1,513 shares over the past year and sold none, though company-wide the year shows 4 insider buys against 34 sells.

Eos Energy revenue up fivefold

EOSE is up 4.9%. GuruFocus flags year-over-year revenue growth of 533.87% from its zinc-based long-duration storage systems, with the price-to-sales ratio at 2.8 against a 10-year median of 22.4. There's no meaningful P/E because the company keeps losing money: trailing EPS of -6.83, an Altman Z-score of -4.34, and a market cap of $617M. GF Score 63/100, with growth ranked 9/10 but financial strength 2/10 and profitability 3/10. Insiders bought $0.8M and sold $18.0M over the past 12 months.

Forgent Power picks up a Clear Street initiation

FPS is up 4.5% after Clear Street started coverage at Buy with a $58 target against a $25.12 price, built on 13x EV/EBITDA calendarised 2029. The firm expects Forgent to grow at five times the sales growth of the broader electrical equipment sector over the next 30 months, citing roughly $4 billion of backlog visibility by December 2026, a 1.8x book-to-bill forecast, order size up 89% over the last twelve months, 16 months of forward revenue visibility, and EBITDA margin expansion of 475 basis points to nearly 28% by the June 2029 fiscal year. It also noted the stock is down 54% from its mid-June high while the iShares AI Innovation & Tech ETF fell 27% over the same stretch. The article recaps a crowded sell-side picture behind it: JPMorgan Overweight at $56 after a Q4 beat, TD Cowen Buy raised to $76 from $73, Bernstein Outperform projecting 70% EPS CAGR through 2030, KeyBanc Overweight, and Wells Fargo at Equal Weight with a $44 target on capacity and execution risk. Fiscal 2027 revenue guidance came in about 20% above consensus.

Vuzix distribution deal

VUZI is up 4.4% on a distribution agreement with Commercial Electronics Systems, a Denver value-added distributor in security and fire protection, which placed an initial six-figure order for LX1 smart glasses and has started shipping. CES is folding Vuzix into a new Automation and Intelligent Infrastructure division and serves commercial customers in Colorado, Texas and Wyoming. The release also notes a CES customer, Merge Solutions, using M400 glasses in surgical procedures including live X-ray streaming.

Vicor rebounds after a violent month

VICR is up 3.9% today, following a roughly 11% jump on Oct 26 that came after a nearly 16% drop the prior Thursday, leaving it down 31% over four weeks. The Q3 10-Q filed Oct 26 showed net revenues of $197.1 million against $110.4 million a year earlier, up 78.5%, helped by a 47.5% rise in Advanced Products revenue on higher royalty income from a new licensing agreement and 18.4% growth in Brick Products. Gross margin was 68.3%, up from 58.0% in the prior quarter on higher volume and a $2.24 million net reduction in freight-in and tariff expense. Net income was $63.3 million, backlog about $406 million, R&D $23.97 million versus $19.86 million, and export sales 36.1% of revenue. Management projects about 10% product revenue growth in Q4. Against that, GuruFocus puts GF Value at $73.01 versus the $194.77 price, calls it 166.8% overvalued with a valuation rank of 1/10 inside an overall GF Score of 82, and notes insiders sold $414.6 million of stock over twelve months with no purchases.

BigBear.ai reports tonight

BBAI is up 3.9% ahead of Q3 results after the close today. The Nasdaq calendar carries a consensus of -$0.05 from two estimates; the GuruFocus preview uses -$0.06 on revenue of $38.94 million, up 17.5% year over year, and notes the company has beaten on EPS half the time and on revenue a quarter of the time over the past year. Price-to-sales is 7.39 against a roughly 3.0x historical median, GF Value sits at $1.47 against a $2.12 price, and GF Score is 52 with financial strength 8/10 (current ratio 5.67, debt-to-equity 0.03) but profitability 1/10 on operating and net margins of -71.17% and -65.2%. No insider buying in twelve months, $0.7 million sold.

TeraWulf higher with no stated catalyst

WULF is up 3.6%. The GuruFocus note covering the move offers no company-specific reason for it, only valuation: price $11.98 against a GF Value of $6.05, GF Score 43 with growth at 0/10 and momentum at 8/10, a forward P/E of 179.1x versus a five-year median of 21.2x, and insiders selling $36.1 million against $0.4 million bought over the past year.

Broadcom and the Anthropic financing

AVGO is up 2.7% on a dense cluster of headline-only items all pointing the same way: Wall Street banks and Blackstone lining up $63 billion to finance Broadcom chips for Anthropic, with Rosenblatt and KeyBanc both reiterating their ratings on the back of it. Several outlets carry variations of the same deal size, including one headline citing $40 billion. I haven't read these in full, so treat the deal structure as unconfirmed beyond the headline.

Coherent, StoneX and the optical complex

COHR is up 2.8%, with headlines saying StoneX initiated coverage at Buy and that Lumentum and Coherent both rose as StoneX backed optical names. Two "Why is Coherent stock surging today?" pieces are headline-only. The one full piece on Coherent is a GuruFocus valuation note built around an older Needham action (Buy maintained, target cut from $420 to $380): it puts GF Value at $105.18 against the $221.50 price, GF Score 79 with valuation ranked 1/10 and growth and momentum both 9/10, P/E of 53.87x against a five-year median of 76.02x, and $8.18 million of insider selling over three months.

ARK rotates out of chips into air taxis

JOBY and TSM carry a +3.4% tag on a piece describing ARK Invest selling 24,796 AMD shares worth about $13.2 million and 21,894 TSMC shares worth about $9.3 million, and using part of the proceeds to buy roughly $4.8 million of Archer Aviation and about $2 million of Joby. The article notes AMD reports Q3 on Nov. 3 with Street expectations of $1.94 EPS on $13.08 billion revenue, Susquehanna at a $620 target and Bernstein Outperform at $650.

Vertiv closes UtilityInnovation deal

VRT is up 2.4% after completing its $1.45 billion acquisition of UtilityInnovation Group, confirmed by an 8-K under Item 2.01. A separate headline says Vertiv launched a pre-engineered AI infrastructure platform. Both headline-only.

Aurora truck deal

AUR is up 2.7% on a headline saying Aurora Innovation shares rose on a new truck deal with Charger Logistics. No detail beyond that.

Celularity filing, no substance

CELU is up 6.7%, but the only item behind it is a Form 13D/A filing notice dated 27 October with no content in the article beyond the headline itself. Nothing there explains the move.

The quieter rest of the list

Everything else moved under 1.5% and the items are headline-only. PayPal, down 0.5%, reported Q3 GAAP EPS of $1.25 beating estimates on revenue of $8.6 billion that missed, with merchant volume also light. Datadog, down 0.6%, drew a UBS target raise to $320 on AI prospects and an Oppenheimer raise to $330. Apple is flat on a very large pile of headlines, mostly ETF-flow items, new MacBook Pro and iPad coverage, and reports that Apple will replace iPhone Duo units showing screen defects. Nothing in that group needs attention today.